A transgenic Syrian hamster model for New World hemorrhagic fever mammarenavirus infection

Read full text Summarise with VIRAT
Authors: Samantha R. Wasson, Yanan Liu, Minghao Li, Kevin W. Bailey, Jonna B. Westover, Julio Landinez-Aponte, Arnaud J. Van Wettere, Venkatraman Siddharthan, Christopher J. Davies, Tracy R. Daniels‐Wells, R Li, Manuel L. Penichet
+2 more Zhongde Wang, Brian B. Gowen
Cited by: 0
References: 72

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Mammarenaviruses are endemic in rodent populations worldwide, and their zoonotic transmission can lead to a severe, life-threatening hemorrhagic fever (HF) syndrome. In the Americas, five New World mammarenaviruses (NWMs) are known to cause HF. As vaccines and antiviral therapy options are limited, these viruses pose a significant public health risk and a threat to national security. Research into NWM pathogenesis and the development of effective countermeasures is restricted by the shortage of small-animal models that faithfully reproduce human disease. The pathogenic NWMs use human transferrin receptor 1 (hTfR1) as the receptor for cellular entry. Here, we describe the development of an hTfR1 knock-in golden Syrian hamster line and its susceptibility to Junín virus (JUNV) infection. This transgenic hamster infection model supports TfR1-mediated entry as an essential step in JUNV pathogenesis and provides a novel small-animal model to advance the development of promising host receptor-directed therapies and direct-acting antivirals to improve outcomes in patients with severe disease caused by pathogenic NWMs.

Fields of Study & Subjects

Viral Infections and Vectors Virology and Viral Diseases Mosquito-borne diseases and control

Publication details

Journal / source
npj Viruses
Publication date
27 October 2026
Language
EN